Bartholdson John A. 4

What Happened

• John A. Bartholdson, a Bioventus director and reported 10% owner (via affiliated Juniper entities), had 32,282 derivative shares recorded as exercised/converted on June 2, 2026 at $0.00 and a corresponding disposed entry of 32,282 shares at $0.00. On June 3, 2026 he was granted 25,146 restricted stock units (RSUs) at $0.00. The RSUs that converted/vested are described in the filing; no cash purchase was reported.

Key Details

• Transaction dates and types:
  • 2026-06-02: Exercise/conversion of derivative (M) — 32,282 shares acquired @ $0.00.
  • 2026-06-02: Corresponding derivative disposition (M) — 32,282 shares disposed @ $0.00.
  • 2026-06-03: Grant/award (A) — 25,146 RSUs granted @ $0.00.
• Price/Value: All entries reported at $0.00; no dollar amounts exchanged in the form.
• Shares owned after transaction: The filing reports beneficial holdings of 6,939,357 Class A shares held by the Juniper entities (4,624,431 + 2,239,076 + 75,850), per footnote; Bartholdson disclaims beneficial ownership except to the extent of his pecuniary interest.
• Vesting and timing notes:
  • Per the filing, the RSUs that converted/vested did so on June 2, 2026 (footnote F4).
  • The new 25,146 RSUs granted on June 3 vest on the earlier of the issuer’s next annual meeting or the first anniversary of grant, subject to continued board service (footnote F5).
• Filing timing: Form 4 filed 2026-06-04 reporting the 2026-06-02 activity (no late filing indicated in the form).

Context

• Derivative/RSU explanation: RSUs represent a contingent right to receive one share each (footnote F3). The filing shows conversion/exercise of vested RSUs into shares (M code) and a contemporaneous disposed entry; both are reported at $0.00. The new RSUs are subject to future vesting conditions.
• Insider status: Bartholdson is reported as a managing member of the Juniper entities that hold the shares and is identified as a 10% owner through those entities; this is institutional/board-level activity rather than an open-market buy or sale by an individual executive.
• Investor takeaway: This filing documents equity compensation activity (vesting/conversion and a new RSU grant) rather than a cash purchase or open-market sale. Such grants and conversions are common for board compensation and do not by themselves indicate a buy/sell sentiment.